Bristol-Myers shares were indicated higher in pre-market trading Monday after the group said a new cancer treatment, which it acquired through its $74 billion takeover of Celgene Corp., had solid results from an early clinical trial. Bristol-Myers said a study …
See Original Article

The chief executive and chairman of Amigo, Britain’s dominant provider of guarantor loans, have resigned in the latest sign of tumult at the high-cost credit provider that once commanded a stock market valuation of more than £1bn. Chief …
See Original Article

Shares of VA Tech Wabag and Ion Exchange climbed over 15 per cent on Monday amid reports that the National Green Tribunal directed 100 per cent treatment of sewage entering the rivers across the country by March 31 next year. The NGT warned that if …
See Original Article

ZURICH (Reuters) – Swiss market supervisor FINMA on Monday allowed Schmolz+Bickenbach’s (STLN.S) big shareholders to increase their stakes without having to make a takeover offer for the entire business, boosting the steelmaker’s fight for survival.
See Original Article

Erwin Singh Braich, the mysterious tycoon behind a $1.2 billion bid to rescue a beleaguered Indian bank, says he is Canada's richest man with a story
See Original Article